Xceleron employs a range of quality control standards designed to characterize and control quantitative analytical LC + AMS methods. These are designed to control as follows:
The transfer of a LC or LC-MS/MS assay for use by LC+AMS entails significant changes and requires care followed by a full validation of the LC+AMS assay. Limited aspects of a previously validated LC or LC-MS/MS may be directly transferrable but insufficient testing of an LC+AMS method may introduce significant risk to the clinical study objectives and developmental timelines.
Xceleron routinely applies the following standards
Xceleron’s use of careful method transfer and three-batch validation has produced reproducible analytical methods that are accurate and precise.
Download our guide to transferring and validating quantitative analytical methods for LC+AMS here
Xceleron is acquired by Pharmaron
"...AMS [is] an invaluable tool in our early drug development program, allowing us to quickly assess bioavailability in humans and focus resources on our most promising drug candidates going forward."
Find out how we can help you accelerate your drug-development program.